# Shionogi

靶向疗法 — 脱靶缓解.

Source: https://cn.bioecon.ru/companies/shionogi/
Updated: 2026-07-02

- 国家: Japan

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 美国政府（Project BioShield项目）为Fetroja国内生产授予$4.82亿合同 | https://www.pharmexec.com/view/shionogi-inc-awarded-482-million-contract-us-government-enhance-national-preparedness-drug-resistant-bacterial-threats |
| 营收 | 2024财年为4383亿日元 | https://www.shionogi.com/content/dam/shionogi/global/investors/ir-library/annual-report-integrated-report/pdf/ir2025/Shionogi25E_78_96.pdf, https://www.shionogi.com/content/dam/shionogi/global/investors/ir-library/annual-securities-report/Annual%20Securities%20Report%20159th.pdf |
| 员工人数 | 截至2024年3月31日（全球合并口径）为5,485名员工 | https://www.shionogi.com/content/dam/shionogi/global/investors/ir-library/annual-report-integrated-report/pdf/ir2025/Shionogi25E_78_96.pdf, https://www.shionogi.com/content/dam/shionogi/global/investors/ir-library/annual-securities-report/Annual%20Securities%20Report%20159th.pdf, https://www.shionogi.com/global/en/sustainability/data.html |
| 生产基地 | 尼崎（Amagasaki）、德岛（Tokushima）及金崎（Kanegasaki）（盐野义制药） | https://www.shionogi-ph.co.jp/en/introduction/bulk_drug.html |
| 产能 | 生产装置规格从台式（0.2公斤/小时）到商业规模（5公斤/小时），再到中大型生产（>500公斤） | https://www.shionogi-ph.co.jp/en/introduction/bulk_drug.html, https://www.shionogi.com/content/dam/shionogi/global/investors/ir-library/annual-report-integrated-report/pdf/ir2025/Shionogi25E_32_56.pdf |

独立来源: pharmexec.com

## 技术

- [抗AMR抗生素](https://cn.bioecon.ru/technology/antibiotics-new-gen-anti-amr/)